Phospho-Aurora A/B/C (T288/232/198) Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F0241-20UL

Regular price €169,00 EUR
Regular price Sale price €169,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Phospho-Aurora A/B/C (T288/232/198) is a target of interest in many antibody-based workflows. Aurora kinases are a novel family of serine/threonine kinases that play crucial roles in regulating mitotic cell division. The family comprises three closely related members: Aurora-A, Aurora-B, and Aurora-C, which are homologs of the yeast Ipll and Drosophila aurora kinases known for their involvement in centrosome function, bipolar spindle assembly, and chromosome segregation. Depending on the literature source, Phospho-Aurora A/B/C (T288/232/198) may also be discussed as Phospho-Aurora A/B/C (T288/232/198) and Phospho Aurora A (Thr 288).

Reported cellular context includes centromere, chromosome, cytoplasm, and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following Phospho-Aurora A/B/C (T288/232/198) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

Phospho-Aurora A/B/C (T288/232/198) is commonly interpreted in the context of cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans centromere, chromosome, and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between centromere, chromosome, and cytoplasm across matched conditions
  • cell-cycle linked differences in abundance, timing, or compartmental enrichment
  • differences between total target abundance and site-specific regulation when modified forms are compared
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Phospho-Aurora A/B/C (T288/232/198). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Phospho-Aurora A/B/C (T288/232/198) reflect biology rather than handling. When interpreting Phospho-Aurora A/B/C (T288/232/198), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Phospho-Aurora A/B/C (T288/232/198) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
AURKA • AURKB • AURKC
Research Area:
Cell Cycle
Application:
FCM • IF • WB
Reactivity:
Human • Mouse • Rat
Specificity:
Phospho-Aurora A/B/C (T288/232/198) Antibody [H12A24] detects endogenous levels of Aurora A/B/C only when phosphorylated at either Thr288, Thr232 or Thr198 respectively.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
H12A24
UniProt:
Q9UQB9Q96GD4O14965
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.